Clinical Trials Directory

Trials / Completed

CompletedNCT05607797

Genetic of Chronic Kidney Disease and Gout in New Caledonia

Genetic of Chronic Kidney Disease and Gout : Analysis of Melanesian Families From New Caledonia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,858 (actual)
Sponsor
Lille Catholic University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The goal of this research is to study the associations of genetic variants of gout and kidney failure, which are very common in the Melanesian population in New Caledonia

Detailed description

Gout is a chronic pathology linked to the deposition in the tissues of monosodium urate (MSU) crystals, secondary to hyperuricemia (high blood levels of urate). Gout causes very painful joint attacks that are first acute and then lead to chronic pain, and disabling deforming manifestations called tophus. The disease is strongly associated with cardiovascular comorbidities and chronic renal failure. In New Caledonia, the prevalence of chronic kidney disease (CKD) (according to the glomerular filtration rate (GFR) \< 60 ml/min) was of 7.4% in 2015 (according to the epidemiological study "Barometer Health 2015"). In the Loyalty Islands, which has overall significantly more Melanesian population, a local database showed that in 2018 the prevalence of patients having at least one blood test reporting kidney disease (GFR CKD\< 60 ml/min) and seen at least once in the previous two years was as follows: * 7.7% in Lifou (9,200 inhabitants) * 8.4% in Maré (5,700 inhabitants) * 9.1% in Ouvéa (3,400 inhabitants) In summary, inflammatory diseases such as CKD and gout have high prevalence in New Caledonia and the Loyalty Islands, and constitute a major health issue. Although the high prevalence of these diseases is probably due in part to non-genetic factors (environment, diet, etc.), it is likely, given the demographic history of this region, that undetected genetic risk alleles among the Melanesian population contribute to the appearance and progression of diseases. Performing genetic and epidemiological studies in an as yet understudied region is essential to identify these variants, which could lead to improved diagnoses and health outcomes.

Conditions

Interventions

TypeNameDescription
OTHEREpidemiological studySociodemographic data collection, treatments collection, physical assessment, clinical examination and physical and biological measurements, biological evaluation (blood and urine samples), CKD-specific clinical features collection, gout-specific clinical features collection, clinical characteristics specific to chronic diseases, questionnaires (Health Assessment Questionnaire (HAQ-II), EuroQol (EQ)-5D-5L, joint pain, state of health, diet and physical activity, access to care, addictions, pain scale (EVA), personal and family history)

Timeline

Start date
2023-03-14
Primary completion
2024-04-30
Completion
2024-04-30
First posted
2022-11-07
Last updated
2024-11-27

Locations

1 site across 1 country: New Caledonia

Source: ClinicalTrials.gov record NCT05607797. Inclusion in this directory is not an endorsement.